<DOC>
	<DOCNO>NCT02747108</DOCNO>
	<brief_summary>This study evaluate effect screen type 2 diabetes mellitus ( T2DM ) brief counsel screen test result weight key health behavior among Veterans risk factor T2DM . Study participant randomly assign one two study group : ( 1 ) Blood Test Group ( 2 ) Brochure Group . Participants Blood Test Group complete blood test call hemoglobin A1c ( HbA1c ) measure average blood sugar level . Participants receive brief counseling result primary care provider someone authorize speak behalf . Participants randomly select Brochure Group review handout VA National Center Health Promotion Disease Prevention ( NCP ) recommend screen test immunization . All participant ask complete survey prior study group assignment , immediately Primary Care appointment , 3 month enrollment , 12 month enrollment .</brief_summary>
	<brief_title>ForgIng New Paths Prevent DIabeTes ( FINDIT )</brief_title>
	<detailed_description>An essential step design effective strategy improve patient engagement behavior change well understand current level engagement behavior determine factor influence engagement . Within outside VHA , little known patient risk factor T2DM view risk develop T2DM , patient understand strategy reduce risk , degree at-risk patient currently engage behavior prevent T2DM . This project generate important new data area improve investigator ' understanding effect prediabetes diagnosis brief counsel engagement behavior prevent T2DM mediator behavior .</detailed_description>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<criteria>The investigator recruit 315 nondiabetic Veterans receive primary care Ann Arbor VA Medical Center meet follow inclusion criterion : willing complete HIPAA authorization form HbA1c result previous 12 month due VA Primary Care appointment approximately 12 week send recruitment letter bodymass index ( BMI ) 30 kg/m2 BMI 25 kg/m2 &gt; 1 obesityrelated condition : hypertension hyperlipidemia Hypoalphalipoproteinemia Coronary Artery Disease Peripheral Vascular Disease Hypertriglyceridemia past hemoglobin A1c ( HbA1c ) 5.7 6.4 past diagnosis Impaired Fasting Glucose ( IFG ) Impaired Glucose Tolerance ( IGT ) Polycystic Ovary Syndrome ( PCOS ) The investigator exclude patient &gt; 75 year age receive chemotherapy cancer , : dementia diabetes dementia New York Heart Association Class III IV congestive heart failure pregnancy Global Initiative Chronic Obstructive Lung Disease ( GOLD ) stage 4 Chronic Obstructive Pulmonary Disease ( COPD ) endstage renal disease ( ESRD ) cirrhosis hospitalize receive rehab stroke myocardial infarction within past 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Veterans</keyword>
	<keyword>Type 2 Diabetes Mellitus</keyword>
	<keyword>Prediabetes</keyword>
	<keyword>Decision-making</keyword>
	<keyword>Motivation</keyword>
	<keyword>Health Promotion</keyword>
	<keyword>Prevention Control</keyword>
</DOC>